Suppr超能文献

智能手表和平板健康设备测量生命体征的准确性:验证研究。

Accuracy of Vital Signs Measurements by a Smartwatch and a Portable Health Device: Validation Study.

机构信息

College of Medicine, Radboud University Medical Center, Nijmegen, Netherlands.

Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, United States.

出版信息

JMIR Mhealth Uhealth. 2020 Feb 12;8(2):e16811. doi: 10.2196/16811.

Abstract

BACKGROUND

New consumer health devices are being developed to easily monitor multiple physiological parameters on a regular basis. Many of these vital sign measurement devices have yet to be formally studied in a clinical setting but have already spread widely throughout the consumer market.

OBJECTIVE

The aim of this study was to investigate the accuracy and precision of heart rate (HR), systolic blood pressure (SBP), diastolic blood pressure (DBP), and oxygen saturation (SpO) measurements of 2 novel all-in-one monitoring devices, the BodiMetrics Performance Monitor and the Everlast smartwatch.

METHODS

We enrolled 127 patients (>18 years) from the Thomas Jefferson University Hospital Preadmission Testing Center. SBP and HR were measured by both investigational devices. In addition, the Everlast watch was utilized to measure DBP, and the BodiMetrics Performance Monitor was utilized to measure SpO. After 5 min of quiet sitting, four hospital-grade standard and three investigational vital sign measurements were taken, with 60 seconds in between each measurement. The reference vital sign measurements were calculated by determining the average of the two standard measurements that bounded each investigational measurement. Using this method, we determined three comparison pairs for each investigational device in each subject. After excluding data from 42 individuals because of excessive variation in sequential standard measurements per prespecified dropping rules, data from 85 subjects were used for final analysis.

RESULTS

Of 85 participants, 36 (42%) were women, and the mean age was 53 (SD 21) years. The accuracy guidelines were only met for the HR measurements in both devices. SBP measurements deviated 16.9 (SD 13.5) mm Hg and 5.3 (SD 4.7) mm Hg from the reference values for the Everlast and BodiMetrics devices, respectively. The mean absolute difference in DBP measurements for the Everlast smartwatch was 8.3 (SD 6.1) mm Hg. The mean absolute difference between BodiMetrics and reference SpO measurements was 3.02%.

CONCLUSIONS

Both devices we investigated met accuracy guidelines for HR measurements, but they failed to meet the predefined accuracy guidelines for other vital sign measurements. Continued sale of consumer physiological monitors without prior validation and approval procedures is a public health concern.

摘要

背景

新的消费者健康设备正在被开发出来,以便定期轻松地监测多个生理参数。许多这些生命体征测量设备尚未在临床环境中进行正式研究,但已经在消费者市场广泛传播。

目的

本研究旨在调查两种新型一体化监测设备(BodiMetrics Performance Monitor 和 Everlast 智能手表)的心率(HR)、收缩压(SBP)、舒张压(DBP)和血氧饱和度(SpO2)测量的准确性和精密度。

方法

我们从托马斯杰斐逊大学医院入院前测试中心招募了 127 名(>18 岁)患者。两种研究设备均测量 SBP 和 HR。此外,Everlast 手表用于测量 DBP,BodiMetrics Performance Monitor 用于测量 SpO2。在安静坐 5 分钟后,每 60 秒进行一次 4 次医院级标准和 3 次研究生命体征测量,每次测量之间间隔 60 秒。参考生命体征测量值是通过确定每个研究测量值的两个边界标准测量值的平均值来计算的。使用这种方法,我们为每个研究设备的每个受试者确定了三个比较对。根据预先指定的剔除规则,剔除了 42 名个体因连续标准测量值变化过大而产生的数据后,对 85 名受试者的数据进行了最终分析。

结果

85 名参与者中,36 名(42%)为女性,平均年龄为 53(21)岁。仅满足了两种设备的 HR 测量的准确性指南。SBP 测量值与 Everlast 和 BodiMetrics 设备的参考值分别相差 16.9(13.5)mmHg 和 5.3(4.7)mmHg。Everlast 智能手表 DBP 测量的平均绝对差值为 8.3(6.1)mmHg。BodiMetrics 和参考 SpO 测量值之间的平均绝对差值为 3.02%。

结论

我们研究的两种设备都满足 HR 测量的准确性指南,但其他生命体征测量的准确性指南未满足。未经事先验证和批准程序就继续销售消费者生理监测仪是一个公共卫生问题。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/024c/7055753/32cfa32bf68c/mhealth_v8i2e16811_fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验